LYMPHADENECTOMY IN UROTHELIAL CARCINOMA IN THE RENAL PELVIS AND URETER

Slides:



Advertisements
Similar presentations
1 Renal Pelvis, Ureter, Bladder and Other Urinary.
Advertisements

Endoscopic diagnosis of upper-tract TCC – Correlating indications, investigations and histology Finch W, Shah N, Wiseman O Addenbrooke’s Hospital Cambridge.
LOGO UPPER URINARY TRACT T.C.C. Presented by: Dr.HashimNaji R3.
In the name of God Isfahan medical school Shahnaz Aram MD.
Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay Barry Stein, M.D. G. Katz, M.D. NMP22.
Principles of Surgical Oncology Done by : 428 surgery team surgery team.
PROTOCOL GO29294 A study evaluating a potential new treatment for locally advanced or metastatic urothelial bladder cancer VERSION 1 | 19 SEPTEMBER 2014.
THE OUTBACK TRIAL A Phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared.
Tumorous nodules in the native kidney in a woman transplanted 3 years earlier because of “chronic pyelonephritis”-induced renal failure B. Ivanyi Department.
Grading And Staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based.
Cancer - renal pelvis or ureter. Overview Cancer of the renal pelvis or ureter is cancer that forms in the pelvis or the tube that carries urine from.
 T1 tumors at high risk of progression (high grade, multifocality, CIS, and tumor size, )  In all T1 patients failing intravesical therapy  muscle-invasive.
Kidney Cancer Like other cancers, kidney or “renal cell” cancer has a family history in 4% of the cases. Familial kidney cancers, like sporadic cases,
Treatment of thyroid nodules Depends on: –FNA cytological examination –Uptake of radioiodine –Size and patient preferences.
Trends in bladder cancer treatments
Erlotinib plus Gemcitabine Compared with Gemcitabine Alone in Patients with Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute.
Bladder Cancer Mark Browning, M.D. ‘ IUSME.
KCR Spring Training T,N,M Case Examples Tonya Brandenburg.
CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal- cell carcinoma after radical nephrectomy: phase III,
Case 3 75 Yr male. pT1 TCC upper ureter. Smoker CKD stage 2 Diabetic Monday morning. Patient admitted for lap nephroureterectomy. Discuss procedure and.
RANDOMIZED PHASE II STUDY OF NABPACLITAXEL, IN RECURRENT ADVANCED OR METASTATIC CERVICAL CANCER MITO CER-NAB Enrica Mazzoni, MD Medical Oncology & Breast.
2016 Edits.
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone inpatients with advanced non-small cell lung cancer and a performance status.
RCR Bladder Cancer Radiotherapy Audit 2016
Canadian Undergraduate Urology Curriculum (CanUUC): Hematuria
KEYNOTE-045: Updated Survival Analysis of Phase III Trial of Pembrolizumab vs Paclitaxel, Docetaxel, or Vinflunine in Pts With Advanced Urothelial Carcinoma.
ELIGIBILITY CRITERIA- Summarised
UROVYSION® FISH Urine Cytology Assessment: Principles and Concepts
CCO Independent Conference Highlights
Underwriting Breast Cancer
A Royal College of Radiologists National Audit of Radiotherapy in the Treatment of Metastatic Spinal Cord Compression and Implications for the Development.
Phase II Study of Docetaxel (D) and Oxaliplatin (O) in Recurrent Metastatic Transitional Cell Carcinoma of the Bladder Davar D1, Appleman LA1, Friedland.
Fondazione IRCCS Istituto Nazionale Tumori
Overzicht activiteiten werkgroep medicamenteuze therapie
Radiology Renal System
BREAST CANCER A full classification includes histopathological type, grade, stage (TNM), receptor status, and the presence or absence of genes as determined.
CT scans: retroperitoneum, bladder, prostate
Endoscopic Treatment of Upper Tract Urothelial Tumours
Jordi Bruix, Maria Reig, Morris Sherman  Gastroenterology 
Yung-Jen Cheng M.D. 國立成功大學附設醫院 放射腫瘤科 Department of Radiation Oncology
Infections of the urinary tract Lecture 3
Radiology Renal System
CT scans: retroperitoneum, bladder, prostate
TUMORS OF THE KIDNEY AND URINARY BLADDER
RTOG 0126 A Phase III Randomized Study of High Dose 3D-CRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer Bijoy.
European Urology Focus
CT Screening for Lung Cancer: Update 2016
Potential and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in Kidney, Prostate, and Bladder Cancer Including Pelvic Lymph Node Staging:
2018/03/18 外科年會 Oral Presentation
Jordi Bruix, Maria Reig, Morris Sherman  Gastroenterology 
10 year-experience of a referral center
URINARY System Two kidneys Two ureters Bladder Urethra.
Excretory System Gross Anatomy.
A Case Report Demonstrating the Potential Clinical Benefit of Exhaustive Molecular Profiling in an Aggressive Muscle-Invasive High-Grade Metastatic Urothelial.
6.11 The Urinary System The Urinary System
Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract  Ji Yun Lee, Kyung Kim, Hyun Hwan Sung, Hwang Gyun Jeon, Byong.
6.11 The Urinary System The Urinary System
Volume 67, Issue 6, Pages (June 2015)
Role of cytokeratins in the diagnosis and prognosis of the bladder cancer Giorgi Adeishvili MD Multiprofile clinic Consilium Medulla.
Volume 73, Issue 1, Pages (January 2018)
Neutrophil / Lymphocyte ratio (NLR)
Case 7.
Volume 69, Issue 4, Pages (February 2006)
Clinical marker confirmation using centrally assessed progression-free survival data in patients with advanced non-small cell lung cancer with non-squamous.
Clinical Utility of the Pretreatment Glasgow Prognostic Score in Patients with Advanced Inoperable Non-small Cell Lung Cancer  Elaine Y.L. Leung, MB ChB,
Combined data from RISC (n=3,024) and San Raffaele dataset (n=1,067)
Jordi Bruix, Maria Reig, Morris Sherman  Gastroenterology 
Sonographic appearance of the upper and lower urinary tract.
Distribution of FGFR aberrancies in urothelial cancers.
Presentation transcript:

LYMPHADENECTOMY IN UROTHELIAL CARCINOMA IN THE RENAL PELVIS AND URETER A RANDOMIZED INTERNATIONAL CLINICAL TRIAL ON LYMPHADENECTOMY IN UROTHELIAL CARCINOMA IN THE RENAL PELVIS AND URETER Next

Inclusion criteria Subjects must provide written informed consent prior to performance of study-specific procedures or assessments, and must be willing to comply with treatment and follow-up. Age ≥ 18 years Eastern Cooperative Oncology Group (ECOG) status of 0-2. Next

Histological defined UTUC: Histologically confirmed diagnosis of predominantly urothelial carcinoma of the upper urinary tract. Yes Positive biopsy for high grade tumor No Back to start

Histological defined UTUC: Histologically confirmed diagnosis of predominantly urothelial carcinoma of the upper urinary tract. Yes Selective upper tract positive cytology No Back to start

Histological defined UTUC: Histologically confirmed diagnosis of predominantly urothelial carcinoma of the upper urinary tract. Yes Micturition positive cytology (if there is no bladder cancer simultaneously) No Back to start

Radiological defined UTUC: Patients with UTUC cT2-T4, N0- M0 (TNM classification): Criteria must to be defined by radiologists. Next Pelvic or calyx tumor Upper 2/3 of ureter Next Back to start

Radiological defined UTUC: Patients with UTUC cT2-T4, N0- M0 (TNM classification): Criteria must to be defined by radiologists. Yes Absence of fat between pelvis and kidney No Back to start

Radiological defined UTUC: Patients with UTUC cT2-T4, N0- M0 (TNM classification): Criteria must to be defined by radiologists. Yes Evidence of parenchymal invasion No Back to start

Radiological defined UTUC: Patients with UTUC cT2-T4, N0- M0 (TNM classification): Criteria must to be defined by radiologists. Yes Growing of tumor out of the renal pelvis No Back to start

Radiological defined UTUC: Patients with UTUC cT2-T4, N0- M0 (TNM classification): Criteria must to be defined by radiologists. Yes Tumor > 1 cm No Back to start

Radiological defined UTUC: Patients with UTUC cT2-T4, N0- M0 (TNM classification): Criteria must to be defined by radiologists. Yes Growing of the tumor out of the ureter No Back to start

Radiological defined UTUC: Patients with UTUC cT2-T4, N0- M0 (TNM classification): Criteria must to be defined by radiologists. Yes Dilation grade 3-4 No Back to start

Radiological defined UTUC: Patients with UTUC cT2-T4, N0- M0 (TNM classification): Criteria must to be defined by radiologists. Yes Tumor > 1 cm No Back to start

Can not included in the study Back to start

Randomization www.UTUC.dk Back to start